stockrowBiohaven Ltd.
BHVN Healthcare Biotechnology
- EPS
- +47.8%
- Free cash flow
- +26.6%
- Total debt
- −1.48%
Quarter to September 2026, against a year earlier
Follow BHVN
Alert me
Biohaven Ltd. (BHVN) Return on invested capital
Biohaven Ltd.'s return on invested capital over the twelve months to 30 September 2026 was −6,659.9%, down 6659.9 percentage points from fiscal 2025 (0.00%). Over the past ten years it has ranged from −13,367.5% (fiscal 2017) to 0.00% (fiscal 2025) — the current reading is the highest in ten years. That is below the Biotechnology industry median of 0.00% and below the Healthcare sector median of 0.00%.
Return on invested capital, annual
Embed this chart
Annual newest first
| Period | Return on invested capital | Change (points) |
|---|---|---|
| FY2025 | 0.00% | 0.00 |
| FY2024 | 0.00% | 590.46 |
| FY2023 | −590.5% | (74.53) |
| FY2022 | −515.9% | (515.93) |
| FY2021 | 0.00% | 0.00 |
| FY2020 | 0.00% | 0.00 |
| FY2019 | 0.00% | 3,004.63 |
| FY2018 | −3,004.6% | 10,362.91 |
| FY2017 | −13,367.5% | (13,367.54) |
| FY2016 | 0.00% | 0.00 |
Against its own ten years
Return on invested capital against peers
| Company | Return on invested capital |
|---|---|
| ADMA ADMA Biologics Inc compare | 48.0% |
| AUPH Aurinia Pharmaceuticals Inc compare | 43.0% |
| VCEL Vericel Corporation compare | 7.88% |
| CLDX Celldex Therapeutics, Inc. compare | 0.00% |
| VERA Vera Therapeutics, Inc. compare | 0.00% |
| LKFT Lakefront Biotherapeutics - Sponsored ADR compare | 0.00% |
| PVLA Palvella Therapeutics, Inc. compare | 0.00% |
| IMNM Immunome, Inc. compare | −3,323.0% |
| BHVN Biohaven Ltd. | −6,659.9% |
| Biotechnology industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Return on invested capital is
Return on Invested Capital shows how much after-tax operating profit a company earns on the money its lenders and shareholders have put in.
TTM: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) (latest quarter) + Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter) − Cash & Short Term Investments (latest quarter)); Annual: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) + Long Term Debt (Total) + Current Part of Debt − Cash & Short Term Investments)